JEV-ED3
(Plasmid
#251259)
-
PurposeTo express the Japanese encephalitis virus envelope protein domain III in E. coli
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 251259 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepET-15b
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameJEV-ED3
-
SpeciesJapanese encephalitis virus
-
Tag
/ Fusion Protein
- 6xHis, 11 aa linker, thrombin cleavage site (N terminal on backbone)
Cloning Information
- Cloning method Other
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
JEV-ED3 was a gift from Yutaka Kuroda (Addgene plasmid # 251259 ; http://n2t.net/addgene:251259 ; RRID:Addgene_251259) -
For your References section:
Neutralizing antibodies against the Japanese encephalitis virus are produced by a 12 kDa E. coli- expressed envelope protein domain III (EDIII) tagged with a solubility-controlling peptide. Islam MD, Islam MM, Inoue A, Yesmin S, Brindha S, Yoshizue T, Tsurui H, Kurosu T, Kuroda Y. Vaccine. 2025 May 22;56:127143. doi: 10.1016/j.vaccine.2025.127143. Epub 2025 Apr 22. 10.1016/j.vaccine.2025.127143 PubMed 40267616